Lexicon Pharma (LXRX) Reports Statistically Significant Data from LX4211 Phase 2b of HbA1c
Go back to Lexicon Pharma (LXRX) Reports Statistically Significant Data from LX4211 Phase 2b of HbA1c| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 2.41 -0.01 (0.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.42 | 52 Week High | $19.62 | |||
| Open | $2.46 | 52 Week Low | $7.65 | |||
| Day High | $2.48 | P/E | N/A | |||
| Day Low | $2.39 | EPS | $-0.22 | |||
| Volume | 1,775,644 | |||||
